Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Current Opinion in Molecular Therapeutics|August 7, 2008
Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic virusesMaxine Bauzon, Terry W HermistonAdvances in Virology|February 8, 2012
Oncolytic viruses: the power of directed evolutionMaxine Bauzon, Terry W HermistonThe Journal of Trauma and Acute Care Surgery|June 19, 2023
Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein CDerek S Sim, Cornell R Mallari, Maxine Bauzon, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Multigene expression from a replicating adenovirus using native viral promotersMaxine Bauzon, Daniel Castro, Michael Karr, et al.Thrombosis Research|May 31, 2022
CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settingsDerek S Sim, Cornell R Mallari, John M Teare, et al.Research and Practice in Thrombosis and Haemostasis|July 15, 2021
In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activityDerek S Sim, Cornell R Mallari, John M Teare, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2007
Development and validation of a robust and versatile one-plasmid regulated gene expression systemPaul Szymanski, Peter J Kretschmer, Maxine Bauzon, et al.Blood Advances|October 29, 2024
Divergent modulation of activated protein C pleiotropic functions by antibodies that differ by a single amino acidDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.Blood Advances|February 3, 2023
Selective modulation of activated protein C activities by a nonactive site-targeting nanobody libraryDerek S Sim, Meenal Shukla, Cornell R Mallari, et al.Frontiers in Immunology|March 8, 2014
Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapyMaxine Bauzon, Terry HermistonPageof 4